An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

NCT01561430 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease

NCT00154635 ·Status: UNKNOWN ·Phase: PHASE2

Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type

NCT01479855 ·Status: UNKNOWN

The Evaluation and Follow-up of Individuals With Memory Disorder

NCT00001480 ·Status: COMPLETED

Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases

NCT02288000 ·Status: TERMINATED ·Phase: PHASE1

A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease

NCT01320527 ·Status: COMPLETED ·Phase: PHASE2

Feasibility and Efficacy of Dietary Interventions for Older Adults With Subjective Cognitive Decline

NCT03585907 ·Status: WITHDRAWN ·Phase: NA

Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients

NCT03514875 ·Status: WITHDRAWN ·Phase: NA

Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease

NCT02221947 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

NCT01466088 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment

NCT02982642 ·Status: WITHDRAWN ·Phase: PHASE4

A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

NCT03114657 ·Status: TERMINATED ·Phase: PHASE3

Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials.

NCT04860414 ·Status: COMPLETED ·Phase: NA

12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease

NCT07034222 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease

NCT03316898 ·Status: WITHDRAWN ·Phase: PHASE1

Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies

NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment

NCT02573740 ·Status: TERMINATED ·Phase: PHASE1

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Hyperhomocysteinemia in Alzheimer's Disease

NCT05793372 ·Status: NOT_YET_RECRUITING

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

NCT02284906 ·Status: TERMINATED ·Phase: PHASE3

Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants

NCT02769065 ·Status: TERMINATED ·Phase: PHASE1

Comparative Research of Alzheimer's Disease Drugs

NCT01362686 ·Status: TERMINATED ·Phase: NA

Vitamin B12 Supplement to Prevent Cognitive Decline

NCT02457507 ·Status: COMPLETED ·Phase: PHASE4

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

NCT04795466 ·Status: TERMINATED ·Phase: PHASE2

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

NCT00722046 ·Status: COMPLETED ·Phase: PHASE2